(19)
(11) EP 4 217 744 A1

(12)

(43) Date of publication:
02.08.2023 Bulletin 2023/31

(21) Application number: 21873644.5

(22) Date of filing: 28.09.2021
(51) International Patent Classification (IPC): 
G01N 33/564(2006.01)
G01N 33/58(2006.01)
C07K 16/28(2006.01)
G01N 33/50(2006.01)
G01N 33/558(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/564; G01N 2333/4716; C07K 16/18; C07K 2317/30
(86) International application number:
PCT/US2021/052437
(87) International publication number:
WO 2022/067259 (31.03.2022 Gazette 2022/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 28.09.2020 US 202063084432 P
27.09.2021 US 202163248962 P

(71) Applicant: Allegheny Singer Research Institute
Pittsburgh, PA 15212 (US)

(72) Inventors:
  • AHEARN, Joseph M.
    Wexford, Pennsylvania 15090 (US)
  • LIU, Chau-Ching
    Pittsburgh, Pennsylvania (US)

(74) Representative: Harrison IP Limited 
3 Ebor House Millfield Lane
Nether Poppleton, York YO26 6QY
Nether Poppleton, York YO26 6QY (GB)

   


(54) METHODS FOR DETERMINING A LEVEL OF A CELL FRAGMENT-BOUND COMPLEMENT ACTIVATION PRODUCT